This is a Study to Evaluate Nanofractures Technique in the Treatment of Cartilage Lesions
Launched by ENTE OSPEDALIERO CANTONALE, BELLINZONA · Dec 20, 2022
Trial Information
Current as of January 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new treatment method called nanofractures for patients with cartilage damage in their knees. Cartilage is a tough tissue that helps cushion the joints, but it doesn't heal well on its own when injured. The study aims to see if nanofractures, which create smaller and less damaging perforations in the bone, can help improve the healing process compared to traditional methods. Researchers will use MRI scans to check how well the cartilage heals after this treatment.
To participate in this trial, you need to be between the ages of 16 and 50 and have cartilage lesions in your knee that require surgery. It's also important that your body mass index (BMI) falls between 18.5 and 30. However, people with certain knee conditions, like severe instability or major misalignment, won't be eligible. If you join this study, you would be contributing to research that could lead to better treatments for knee cartilage injuries in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with cartilage lesions of the knee scheduled for surgery
- • Age 16-50
- • BMI between 18.5 and 30 points
- • Ability to give informed consent
- Exclusion Criteria:
- • Uncorrected knee instability
- • Meniscectomy \> 50%
- • Uncorrected knee misalignment
- • Uncontrolled metabolic diseases
- • Inability to give informed consent
Trial Officials
Luca Deabate, MD
Principal Investigator
Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland
About Ente Ospedaliero Cantonale, Bellinzona
Ente Ospedaliero Cantonale (EOC) in Bellinzona is a prominent healthcare institution dedicated to providing high-quality medical services and advancing clinical research. As a key sponsor of clinical trials, EOC focuses on fostering innovative healthcare solutions and improving patient outcomes through rigorous scientific inquiry. With a commitment to ethical standards and collaboration, EOC plays an essential role in the development of new therapies and medical practices, leveraging its expertise and resources to contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lugano, , Switzerland
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials